Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Briacell Therapeutics Corp
T.BCT
Alternate Symbol(s):
BCTX
|
BCTXW
|
BCTXZ
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted...
immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:BCT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
•••
Jonathon Brown
X
Post by
Jonathon Brown
on May 08, 2025 9:17am
Buzz on the Bullboards: From oil fields to labs, TSX Stories making waves
Several TSX and TSX Venture-listed companies made significant announcements that could shape their near-term trajectories.
read article.
(16)
•••
wallpaper2
X
Post by
wallpaper2
on May 01, 2025 5:10am
Really
"Taking off" "Big upswing" "Shorts covering"
(130)
•••
loopsbutterfly
X
Comment by
loopsbutterfly
on Apr 24, 2025 11:07am
RE:RE:Buy buddy buy because it's taking off this morning.
Some profit taking as expected but IT is holding quitte well info the $9.00 level
(130)
•••
loopsbutterfly
X
Post by
loopsbutterfly
on Apr 24, 2025 9:35am
Stock chart says
IT is going to $20 in the Near term not too many shares ou standing at the moment Gracias. Grinnnn
(130)
•••
loopsbutterfly
X
Comment by
loopsbutterfly
on Apr 24, 2025 8:40am
RE:Buy buddy buy because it's taking off this morning.
Oh yeah and IT is already at $12 pre-market Trade Finally this stock Will get some respect and short sellers or nake short Will be catch on IT this morning Go bct go !!!
(215)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Apr 24, 2025 8:17am
Buy buddy buy because it's taking off this morning.
This stock is signalling a big upswing for it today
(16)
•••
wallpaper2
X
Comment by
wallpaper2
on Feb 12, 2025 12:29pm
RE:New BUY rating today.
Buy ratings, analyst reports etc.are paid for....my broker likened them to whores...pay them enough and they will give you anything you want.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 05, 2025 6:16pm
New Press Release - BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
PHILADELPHIA, Pa. and VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 05, 2025 4:05pm
New Press Release - BriaCell Therapeutics Announces Closing of Public Offering
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the...
read article.
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 05, 2025 10:14am
BCTX....sold all into the strength
I like to leave some for the next guy ; )
(63)
•••
opsd1
X
Post by
opsd1
on Feb 04, 2025 9:41am
New BUY rating today.
Price target of $46.53.
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 04, 2025 8:17am
BCTX.....Now that the ~700K sh P.O @ $4 is priced
Might be worth putting this on watch list ; )
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 04, 2025 8:14am
RE:I don't understand
Now u know why they call it an "Underwriting" TBH...... they did a RS on 01/27/25.....this game is all about raising money....so the 700K P.O @ $4 is basically done to replenish the
...more
(859)
•••
Pandora
X
Comment by
Pandora
on Feb 03, 2025 8:20pm
RE:RE:I don't understand
How about todays offering at $4?
(130)
•••
loopsbutterfly
X
Comment by
loopsbutterfly
on Feb 03, 2025 5:38pm
RE:I don't understand
You forget the 1 for 15 stock consolidation lately
(63)
•••
opsd1
X
Post by
opsd1
on Feb 03, 2025 3:32pm
BriaCell Announces Resolution of Lung Metastasis in First
Patient treated with Bria-OTS(TM) https://stockhouse.com/news/press-releases/2025/02/03/briacell-announces-resolution-of-lung-metastasis-in-first-patient-treated-with
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This company is set to benefit from a change in Ontario legislation
Largest integrated facility services provider in Canada releases financial results for Q1, 2025
How Web3 Will Fundamentally Reshape Finance